Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Lottery.com, a Leading Platform to Play the Lottery Online, Enters into Definitive Agreement with Trident Acquisitions Corp. to Become Publicly Traded
-
Sensorion : A Chardan Top Pick for 2021
-
Form SC 13G Chardan Healthcare Acqui Filed by: PERISCOPE CAPITAL INC.
-
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
-
Quantum FinTech Acquisition Corporation Announces Exercise and Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
-
Quantum FinTech Acquisition Corporation Announces Exercise and Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
-
Editas Medicine (EDIT) PT Raised to $77 at Chardan Capital Markets
-
Intellia Therapeutics (NTLA) PT Raised to $85 at Chardan Capital Markets
-
Enterome Presenting at Upcoming Investor Meetings
-
Quantum FinTech Acquisition Corporation Announces Closing of $175 Million Initial Public Offering
-
Quantum FinTech Acquisition Corporation Announces Closing of $175 Million Initial Public Offering
-
Pre-Open Stock Movers 02/09: (KALV) (HTBX) (GLUU) Higher; (BRPA) (INFI) (OCGN) Lower (more...)
-
Chardan Capital Markets Downgrades Ocugen, Inc. (OCGN) to Neutral Following Run-Up
-
IPO for SPAC Quantum FinTech Acquisition Corp (QFTA) Opens at $10.32
-
Quantum FinTech Acquisition Corp. (QFTA) Prices 17.5M Unit IPO at $10/Unit
-
Quantum FinTech Acquisition Corporation Announces Pricing of Upsized $175 Million Initial Public Offering
-
Quantum FinTech Acquisition Corporation Announces Pricing of Upsized $175 Million Initial Public Offering
-
Viveon Health Acquisition Corp. Announces the Separate Trading of its Common Stock, Warrants and Rights Commencing February 4, 2021
-
Viveon Health Acquisition Corp. Announces the Separate Trading of its Common Stock, Warrants and Rights Commencing February 4, 2021
-
Form SC 13G Chardan Healthcare Acqui Filed by: K2 PRINCIPAL FUND, L.P.
-
Natural Order Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants Commencing January 29, 2021
-
Natural Order Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants Commencing January 29, 2021
-
La Jolla Pharma (LJPC) PT Lowered to $15 at Chardan Capital Markets
-
Passage Bio (PASG) Prices 7M Share Common Offering at $22/Sh
-
Passage Bio Announces Pricing of Public Offering
-
Passage Bio Announces Pricing of Public Offering
-
Passage Bio (PASG) Announces Launch of 7M Share Proposed Public Offering
-
Passage Bio Announces Launch of Proposed Public Offering
-
Passage Bio Announces Launch of Proposed Public Offering
-
Krystal Biotech (KRYS) Selected as a 'Top Pick' for 2021 by Chardan Capital, Sees 3-4 Major Catalysts
-
Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering
-
Meten EdtechX Announces Completion of its Offer to Exercise Warrants at a Reduced Price
-
Buy Solid Biosciences (SLDB) on Weakness - Chardan Capital
-
UPDATE: Chardan Capital Markets Starts Cabaletta Bio Inc. (CABA) at Buy, $21 PT
-
Mountain Crest Acquisition Corp. II (MCAD) Prices 5M Unit IPO at $10/Unit
-
Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering
-
Sensorion Announces Initiation of Coverage by Investment Banks Jefferies and Kempen With a “Buy” Recommendation
-
Chardan Capital Markets Starts Vincera Pharma (VINC) at Buy, $33 PT
-
Form 4 Ventoux CCM Acquisition For: Jan 05 Filed by: Chardan International Investments, LLC
-
Ventoux CCM Acquisition Corp. Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering
-
Provention Bio Inc. (PRVB) PT Raised to $40 at Chardan Capital Markets
-
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
-
Form 4 Ventoux CCM Acquisition For: Dec 30 Filed by: Chardan International Investments, LLC
-
Viveon Health Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
Viveon Health Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
Ventoux CCM Acquisition Corp. Announces Closing of $150 Million Initial Public Offering

